BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7337470)

  • 1. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)].
    Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL
    Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophysiological properties of mexiletine. Experimental study in the dog (author's transl)].
    Puech P; Roca J; Molina L; de Boisjelin X; Sassine A; Masse C
    Ann Cardiol Angeiol (Paris); 1979; 28(3):189-93. PubMed ID: 507724
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of the new antiarrhythmic drug mexiletine on sinus node and intracardiac conduction in man (author's transl)].
    Seipel L; Breithardt G; Schoerner U
    Z Kardiol; 1978 Nov; 67(11):766-70. PubMed ID: 726555
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electrophysiologic actions of mexiletine (Kö-1173) in man].
    González Maqueda I; García Fernández F; Martín Jadraque L
    Med Clin (Barc); 1981 Mar; 76(5):223-5. PubMed ID: 7206892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiological study of the mexiletine (author's transl)].
    Ebagosti A; Lodovici F; Escojido H; Torresani J; Jouve A
    Ann Cardiol Angeiol (Paris); 1979; 28(3):181-8. PubMed ID: 507723
    [No Abstract]   [Full Text] [Related]  

  • 7. Mexiletine effect on monophasic action potential (MAP) of right ventricle in man.
    Olsson SB; Harper RW
    Acta Med Scand Suppl; 1978; 615():93-8. PubMed ID: 279227
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiologic effects of mexiletine on normal and ischemic ventricles.
    Yoon MS; Han J
    J Electrocardiol; 1982 Apr; 15(2):109-13. PubMed ID: 7069325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of mexiletine on left ventricular ejection: a comparison with lignocaine and propranolol.
    Shaw TR
    Postgrad Med J; 1977; 53 Suppl 1():69-73. PubMed ID: 876955
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies on heart-lung-preparation of dog. Effect of various antiarrhythmic active substances on the contractility, rate of conductivity, refractory phase and excitability of heart].
    Igarashi T; Shyoji T
    Arzneimittelforschung; 1968 Nov; 18(11):1368-72. PubMed ID: 5755899
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the effect of Melixetin (Kö 1173) on AV-conduction time and sinus pulse automation in persons with healthy hearts and in patients with disorders of the impulse-conduction system].
    Lang KF; Just H; Limbourg P
    Z Kardiol; 1975 May; 64(5):389-95. PubMed ID: 1189534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
    Yamaguchi I; Singh BN; Mandel WJ
    Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman DC; Dunning AJ
    Postgrad Med J; 1977; 53 Suppl 1():92-6. PubMed ID: 876958
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrophysiological and other effects on cardiac function of KO 1173.
    Singh BN; Williams EM
    Br Heart J; 1973 May; 35(5):558. PubMed ID: 4716038
    [No Abstract]   [Full Text] [Related]  

  • 16. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mexiletine on conduction of premature ventricular beats in man: a study using monophasic action potential recordings from the right ventricle.
    Harper RW; Olsson SB
    Cardiovasc Res; 1979 Jun; 13(6):311-9. PubMed ID: 476752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Clinical electrophysiological effects of mexiletine and its mechanism of antidysrhythmic action.
    McComish M; Crook B; Kitson D; Jewitt D
    Br Heart J; 1976 Mar; 38(3):311. PubMed ID: 1259850
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1981 Oct; 74(2):381-8. PubMed ID: 7317687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical electrophysiological effects of mexiletine.
    McComish M; Kitson D; Robinson C; Jewitt DE
    Postgrad Med J; 1977; 53 Suppl 1():85-91. PubMed ID: 876957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.